Related Experiment Videos
[Kinetics and clinical application of 99mTc-technegas]
K Kawakami1, A Iwamura, E Goto
1Department of Radiology, Jikei University School of Medicine.
Kaku Igaku. the Japanese Journal of Nuclear Medicine
|July 1, 1990
Summary
Technetium-99m-labeled Technegas is a safe and effective radiopharmaceutical for lung ventilation imaging. It provides clear visualization of ventilation abnormalities, outperforming older methods.
Area of Science:
- Nuclear Medicine
- Radiopharmacology
- Pulmonary Imaging
Background:
- 99mTc-Technegas is a radiopharmaceutical used for lung ventilation studies.
- Previous methods like 133Xe gas have limitations in visualizing ventilation defects.
Purpose of the Study:
- To evaluate the biological characteristics and clinical utility of 99mTc-Technegas.
- To compare 99mTc-Technegas with other ventilation imaging agents.
Main Methods:
- Inhalation of 99mTc-Technegas by normal volunteers and patients with pulmonary diseases.
- Assessment of biodistribution, biological half-time, and radiation dose.
- Comparison with 81mKr gas, 133Xe gas, and 99mTc-aerosol.
Main Results:
- 99mTc-Technegas primarily distributes to the lungs (95%).
- Biological half-time in the lung is 135 hours; images remain stable for 24 hours.
- Pulmonary imaging with 99mTc-Technegas clearly identifies ventilation abnormalities, superior to 133Xe, and visualizes more peripheral sites than 99mTc-aerosol.
Conclusions:
- 99mTc-Technegas inhalation study is a safe and valuable method for pulmonary ventilation imaging.
- It offers improved visualization of ventilation defects compared to 133Xe gas.
- It complements other methods like 99mTc-aerosol for comprehensive ventilatory assessment.